Results 51 to 60 of about 7,314 (220)

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. [PDF]

open access: yesPLoS Pathogens, 2012
The contribution of innate immunity to immunosurveillance of the oncogenic Human Herpes Virus 8 (HHV8) has not been studied in depth. We investigated NK cell phenotype and function in 70 HHV8-infected subjects, either asymptomatic carriers or having ...
Stéphanie Dupuy   +7 more
doaj   +1 more source

Extracavitary Manifestation of Primary Effusion Lymphoma as a Right Atrial Mass [PDF]

open access: yes, 2013
Primary effusion lymphoma (PEL) is a subset of large B cell lymphomas and has been mostly associated with human immunodeficiency virus infection. Rare cases have been reported in organ transplant recipients and chronic hepatitis C patients.
Guddati, Achuta K   +4 more
core   +2 more sources

KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV

open access: yesHemato, 2021
In 1992, Kaposi sarcoma herpesvirus (KSHV/HHV8) was discovered and identified as the causative agent for Kaposi sarcoma. Subsequently, the presence of this virus has been detected in a number of lymphoproliferative disorders in people living with HIV ...
Mark Bower, Antonino Carbone
doaj   +1 more source

Role of GBV-C and human herpes virus coinfections in AIDS development in HIV-1 seroconverters [PDF]

open access: yes, 2014
Background: GB virus type C (GBV-C) co-infection prolongs survival among Human Immunodeficiency Virus (HIV) infected individuals. Chronic immune activation is associated with HIV-1 disease progression.
Shen, Chengli
core   +1 more source

Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference [PDF]

open access: yes, 2013
The burden of infectious diseases both before and after liver transplantation is clearly attributable to the dysfunction of defensive mechanisms of the host, both as a result of cirrhosis, as well as the use of immunosuppressive agents.
2011 AISF Single Topic Group   +12 more
core   +1 more source

Human herpesvirus 8 (HHV8) sequence variations in HHV8 related tumours in Okinawa, a subtropical island in southern Japan [PDF]

open access: yesJournal of Clinical Pathology, 2004
Background: Although rare in mainland Japan, classic Kaposi’s sarcoma (KS) is frequently reported in Okinawa, a subtropical island in southern Japan. Human herpesvirus 8 (HHV8) has been identified in the tumours and geographical differences occur. Aim:
K, Kamiyama   +7 more
openaire   +2 more sources

Cardiac Involvement by Human Herpesvirus 8-Positive Diffuse Large B-Cell Lymphoma: An Unusual Presentation in a Patient with Human Immunodeficiency Virus

open access: yesCase Reports in Pathology, 2022
Human immunodeficiency virus (HIV) infection predisposes patients to the development of lymphomas, both due to immune suppression and coinfection with viruses with oncogenic potential.
Elena M. Fenu   +3 more
doaj   +1 more source

Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults

open access: yesFrontiers in Immunology, 2023
BackgroundHuman Herpesvirus-8 (HHV-8) is the etiologic agent of Kaposi’s sarcoma (KS), a multicentric angio-proliferative cancer commonly associated with Human Immunodeficiency Virus (HIV) infection.
Benderli Christine Nana   +21 more
doaj   +1 more source

Vírus causadores de câncer e o papel da medicina laboratorial: revisão de literatura e perspectivas [PDF]

open access: yes, 2013
Cancer-causing viruses are responsible for up to 20% of cancers with infectious etiology, representing a serious public health problem worldwide. Since the discovery of the first human cancer-causing virus, several others have been associated with ...
Granato, Celso Francisco Hernandes   +1 more
core   +3 more sources

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

open access: yesTransplant Infectious Disease, Volume 28, Issue 2, March/April 2026.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy